BONINI, Sergio
 Distribuzione geografica
Continente #
EU - Europa 10.445
NA - Nord America 4.997
AS - Asia 3.921
SA - Sud America 904
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 20.341
Nazione #
RU - Federazione Russa 6.277
US - Stati Uniti d'America 4.950
SG - Singapore 1.620
IE - Irlanda 1.321
UA - Ucraina 985
HK - Hong Kong 816
BR - Brasile 762
CN - Cina 749
GB - Regno Unito 641
DE - Germania 401
FI - Finlandia 257
SE - Svezia 191
VN - Vietnam 178
IN - India 163
TR - Turchia 158
GR - Grecia 152
IT - Italia 103
KR - Corea 54
AR - Argentina 46
JP - Giappone 42
ID - Indonesia 30
EC - Ecuador 26
BE - Belgio 25
BD - Bangladesh 24
FR - Francia 24
CA - Canada 17
AT - Austria 16
CO - Colombia 16
MX - Messico 16
IQ - Iraq 14
PK - Pakistan 14
VE - Venezuela 14
PY - Paraguay 12
ZA - Sudafrica 11
JO - Giordania 10
UY - Uruguay 10
NL - Olanda 9
TN - Tunisia 9
DZ - Algeria 8
CL - Cile 7
EU - Europa 7
KE - Kenya 7
PE - Perù 7
PL - Polonia 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 5
ES - Italia 5
IL - Israele 5
LT - Lituania 5
MA - Marocco 5
UZ - Uzbekistan 5
BO - Bolivia 4
EG - Egitto 4
LB - Libano 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AP - ???statistics.table.value.countryCode.AP??? 3
AU - Australia 3
GG - Guernsey 3
IR - Iran 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
LV - Lettonia 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
Totale 20.336
Città #
Moscow 2.138
Jacksonville 1.464
Dublin 1.317
Hong Kong 816
Santa Clara 562
Chandler 552
Singapore 386
Princeton 245
Medford 234
San Mateo 167
Boardman 160
Ashburn 117
Wilmington 115
Bengaluru 104
Ann Arbor 89
Hefei 82
The Dalles 74
Woodbridge 66
Dallas 63
Beijing 62
Ho Chi Minh City 60
Roxbury 56
Cambridge 54
São Paulo 52
Hanoi 39
Seoul 37
Des Moines 36
Rio de Janeiro 27
New York 23
Brasília 19
Brussels 18
Redwood City 18
Mountain View 17
Nanjing 17
Rome 17
Belo Horizonte 16
Pune 16
Düsseldorf 15
Houston 14
Jinan 13
Los Angeles 13
Campinas 12
Curitiba 12
Nuremberg 12
Kunming 11
Norwalk 11
Quito 11
Shanghai 11
Dhaka 10
Hangzhou 10
Bogotá 9
Haiphong 9
Munich 9
Salvador 9
Tianjin 9
Caxias do Sul 8
Da Nang 8
Lappeenranta 8
London 8
Montevideo 8
Vienna 8
Fairfield 7
Guangzhou 7
Nova Iguaçu 7
Auburn Hills 6
Brooklyn 6
Fortaleza 6
Manaus 6
Montes Claros 6
Nairobi 6
Santo André 6
Seattle 6
Amman 5
Asunción 5
Bauru 5
Betim 5
Bremen 5
Changsha 5
Città di Castello 5
Contagem 5
Goiânia 5
Haikou 5
Jakarta 5
Jinju 5
Joinville 5
Nanchang 5
Orange 5
Santos 5
São Gabriel 5
São José dos Campos 5
Toronto 5
Tunis 5
Americana 4
Aracaju 4
Atlanta 4
Baghdad 4
Blumenau 4
Bắc Giang 4
Canoas 4
Catanduva 4
Totale 9.784
Nome #
Global Allergy and Asthma European Network: Grading of Recommendations Assessment, Development and Evaluation Working Group: Allewrgic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision 271
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization 161
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open-field farmers living in a temperate climate area 144
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project 138
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 125
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 121
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 120
[New methods in allergology] 119
Allergenic pollen and pollen allergy in Europe 116
Uso del Fattore di crescita nervoso (NGF)per l'espansione in vitro di cellule staminali del cordone ombelicale 116
Allergen extracts. Standardization of preparations for bronchial provocation tests. A position paper. (EAACI Sub-committee on Bronchial Provocation Tests) 115
GA2LEN (GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK) ADDRESSES THE ALLERGY AND ASTHMA 'EPIDEMIC' 113
Allergen immunotherapy on the way to product-based evaluation - a WAO statement 113
GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases 112
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 111
The genetics of atopy 108
Allergic conjunctivitis 108
[Phadiatop, a new in vitro method in the diagnosis and prevention of respiratory allergic diseases] 108
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche 107
POLLENOSIS 2000. GLOBAL APPROACH 107
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. 106
[Autoimmunity and lymphoproliferative diseases (proceedings)] 106
GA(2)LEN SKIN TEST STUDY II: CLINICAL RELEVANCE OF INHALANT ALLERGEN SENSITIZATIONS IN EUROPE 105
Microbial products in allergy prevention and therapy 105
Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation 104
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 104
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 104
T-helper 17 lymphocytes in ocular cicatricial pemphigoid 104
Allergic Conjunctivitis 104
Integrated care pathways for airway diseases (AIRWAYS-ICPs). 103
Allergic bronchial airway inflammation in Nerve Growth Factor (NGF) – derived rats: evidence suggesting a neuroimmunomodulatory role of NGF 103
Immunological aspects of chronic uremia 103
GA(2)LEN SKIN TEST STUDY I: GA(2)LEN HARMONIZATION OF SKIN PRICK TESTING: NOVEL SENSITIZATION PATTERNS FOR INHALANT ALLERGENS IN EUROPE 101
The eosinophil and the eye 101
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. 101
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One 100
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network 100
Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat 100
Allergen dose response and late symptoms in a human model of ocular allergy 100
EXERCISE-INDUCED ASTHMA, RESPIRATORY AND ALLERGIC DISORDERS IN ELITE ATHLETES: EPIDEMIOLOGY, MECHANISMS AND DIAGNOSIS: PART I OF THE REPORT FROM THE JOINT TASK FORCE OF THE EUROPEAN RESPIRATORY SOCIETY (ERS) AND THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) IN COOPERATION WITH GA2LEN 99
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 99
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis 99
Evidence of non reproducibility. Human basophil histamine release is not triggered by very diluted anti-IgE. Letter 99
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN 98
Reply to the letter of Dr. Feinberg in J Allergy Clin Immunol 1990; 85:141-2 98
Epidemiology of asthma, allergy and bronchial hyperresponsiveness in sports 98
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 97
Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface 97
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma 97
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 97
Immunological profile of peripheral blood eosinophils in acute graft-vs-host disease 96
Airway inflammation in the elite athlete and type of sport 96
Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens 96
Barriers to new drug development in respiratory disease 96
A survey of clinical features of allergic rhinitis in adults. 96
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 95
Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis 95
WHO Intiative. Allergic Rhinitis and its Impact on Asthma (ARIA) 95
Allergic Eye Disorders 95
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA(2)LEN - ARIA Position Paper. 94
Nerve Growth Factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 94
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper 94
CLOSE CORRELATION BETWEEN ANXIETY; DEPRESSION; AND ASTHMA CONTROL, 94
Allergic conjunctivitis: the forgotten disease 94
Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas 93
Epidemiology of rhinitis and conjunctivitis in athletes. 93
Reply 93
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. 93
Flow cytometric evaluation of activated eosinophils in graft versus host disease and hypereosinophilic conditions 93
Primer di Allerghologia e Immunologia Clinica 93
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. 92
GA2LEN SKIN TEST STUDY III: MINIMUM BATTERY OF TEST INHALENT ALLERGENS NEEDED IN EPIDEMIOLOGICAL STUDIES IN PATIENTS 92
Copyright. AQUE. Allergy Questionnaire for Exercisers 92
Desloratadine: a new approach in the treatment of allergy as a systematic disease--pharmacology and clinical overview. Introduction 91
Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure 91
Desloratadina: a new approach in the treatment of allergy as a systemic disease - pharmacology and clinical overview 91
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? 90
Tear tryptase levels and allergic conjunctivitis 90
Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro 90
Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper 89
The relation between paracetamol use and asthma: a GA2LEN European case-control study 89
Effects of Salmeterol on Skeletal Muscle Cells: Metabolic and Pro-Apoptotic Features. 89
Nerve Growth Factor has a modulatory role on human primary fibroblast coltures derived from vernal keratoconjunctivitis-affected conjunctiva 89
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) 89
Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. 89
International consensus on allergy immunotherapy 89
First-in-human clinical trials - What we can learn from tragic failures 89
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 89
Intestinal permeability in patients with adverse reactions to food 88
What we should learn from the London Olympics. 88
EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens 88
Non specific provocation of target organs in allergic diseases 87
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document 87
Markers of eosinophilic inflammation in allergic diseases 87
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta 87
Global Approach to the atopic Patient 87
Asthma and dietary intake: An overview of systematic reviews 87
Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review 86
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). 84
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy. 84
Totale 10.113
Categoria #
all - tutte 73.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.000 0 0 0 0 0 4 254 245 0 281 181 35
2021/20221.233 173 1 2 14 492 3 20 38 46 4 94 346
2022/20232.186 251 3 8 169 190 179 1 146 1.151 12 43 33
2023/2024912 72 23 31 131 374 37 4 30 13 9 40 148
2024/20252.877 13 20 27 62 367 258 512 277 352 641 214 134
2025/20268.820 374 342 572 659 801 6.072 0 0 0 0 0 0
Totale 20.419